Literature DB >> 22812926

Visual signs and symptoms of dementia with Lewy bodies.

Richard A Armstrong1.   

Abstract

Dementia with Lewy bodies ('Lewy body dementia' or 'diffuse Lewy body disease') (DLB) is the second most common form of dementia to affect elderly people, after Alzheimer's disease. A combination of the clinical symptoms of Alzheimer's disease and Parkinson's disease is present in DLB and the disorder is classified as a 'parkinsonian syndrome', a group of diseases which also includes Parkinson's disease, progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. Characteristics of DLB are fluctuating cognitive ability with pronounced variations in attention and alertness, recurrent visual hallucinations and spontaneous motor features, including akinesia, rigidity and tremor. In addition, DLB patients may exhibit visual signs and symptoms, including defects in eye movement, pupillary function and complex visual functions. Visual symptoms may aid the differential diagnoses of parkinsonian syndromes. Hence, the presence of visual hallucinations supports a diagnosis of Parkinson's disease or DLB rather than progressive supranuclear palsy. DLB and Parkinson's disease may exhibit similar impairments on a variety of saccadic and visual perception tasks (visual discrimination, space-motion and object-form recognition). Nevertheless, deficits in orientation, trail-making and reading the names of colours are often significantly greater in DLB than in Parkinson's disease. As primary eye-care practitioners, optometrists should be able to work with patients with DLB and their carers to manage their visual welfare.
© 2012 The Author; Clinical and Experimental Optometry © 2012 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2012        PMID: 22812926     DOI: 10.1111/j.1444-0938.2012.00770.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  4 in total

1.  Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies.

Authors:  Takashi Nakata; Kenichi Shimada; Akiko Iba; Haruhiko Oda; Akira Terashima; Yutaka Koide; Ryota Kawasaki; Takahiro Yamada; Kazunari Ishii
Journal:  Ann Nucl Med       Date:  2022-01-29       Impact factor: 2.668

2.  Gene expression profiling of brain samples from patients with Lewy body dementia.

Authors:  Maciej Pietrzak; Audrey Papp; Amanda Curtis; Samuel K Handelman; Maria Kataki; Douglas W Scharre; Grzegorz Rempala; Wolfgang Sadee
Journal:  Biochem Biophys Res Commun       Date:  2016-09-22       Impact factor: 3.575

Review 3.  Genetic markers in biological fluids for aging-related major neurocognitive disorder.

Authors:  S A Castro-Chavira; T Fernandez; H Nicolini; S Diaz-Cintra; R A Prado-Alcala
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 4.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.